Pancreatic Cancer Action Network

Last updated
Pancreatic Cancer Action Network
FoundedFebruary 8, 1999;24 years ago (1999-02-08) [1]
33-0841281 [2]
Legal status 501(c)(3) nonprofit organization [3]
Headquarters Manhattan Beach, California, United States [2]
Julie Fleshman [2]
Chairman of the Board
Jeanne Weaver [2]
Revenue (2018)
$51,943,557 [2]
Expenses (2018)$32,849,702 [2]
Employees (2018)
150 [2]
Volunteers (2018)
2,620 [2]
Website www.pancan.org

The Pancreatic Cancer Action Network (PanCAN) is a United States-based 501(c)(3) charity that funds research, provides patient/caregiver support, conducts community outreach and advocates for increased federal research funding for those affected by pancreatic cancer. [4] [5]

Contents

Since the disease is projected to become the second leading cause of cancer-related death in the U.S. around 2020, [6] the organization established a goal, called the "Vision of Progress", to double pancreatic cancer survival by 2020. [4] The nonprofit seeks to fulfill the goal by spreading greater awareness and increasing funds for research to improve the prevention, diagnosis and treatment of pancreatic cancer. [4]

One way PanCAN raises awareness and funds is through the 5K walk/run event, PurpleStride. The events include more than 80,000 participants in nearly 60 communities in the United States, which are organized by local volunteer affiliates. [7]

History

The Pancreatic Cancer Action Network was founded in February 1999 by a group of survivors and caregivers including Pamela Acosta Marquardt, Paula Kim and Terry Lierman. [8] Their first advocacy event, called "Inaugural One Voice Against Cancer", took place in Washington, D.C., in 2000. [9] By 2002, the organization had created 40 volunteer affiliates across the U.S. [9] In 2006, the first international affiliate started in Japan, and the Government Affairs & Advocacy office opened in Washington, D.C. [9]

The Patient Central call center had helped 25,000 patients and caregivers by 2007. [9] They formed the Deadliest Cancers Coalition in 2008 involving other professional organizations. [9] In 2013, their PurpleStride 5K walk/run event raised over $10.5 million with almost 82,000 participants. [9]

The organization initiated Know Your Tumor in 2014, a precision medicine service that uses molecular profiling to give doctors and their patients details about the biology of their tumor to help with treatment choices. [10] In 2015, they launched the Clinical Trial Finder online resource with a directory of U.S. pancreatic cancer clinical trials. [11] Precision Promise was announced in 2016 as the first precision medicine clinical trial to get new therapies to pancreatic cancer patients faster. [12]

From 2008–2016, PanCAN's community events generated more than $87 million for the pancreatic cancer cause. [9] The total research investment of the organization since 2003 is approximately $104 million to date. [9]

PanCAN is headquartered in Manhattan Beach, California, and also staffs a Washington, D.C., and New York City office.

Research

The Pancreatic Cancer Action Network funds grants for biomedical research in order to better understand the causes of pancreatic cancer and to advance its prevention, detection, treatment and cure. [13] The organization offers grants for basic, translational and clinical research in pancreatic cancer to scientists and clinicians at various career levels. [14]

PanCAN has awarded 174 grants to 170 scientists at 64 institutions with a cumulative projected research investment close to $104 million from 2003 to date, inclusive of their Research Grants Program and internal research initiatives. [15]

The organization evaluated grants awarded from 2003 to 2015, which showed 122 grants given to 123 researchers, totaling over $28.2 million. [16] The grantees leveraged the $28.2 million awarded by PanCAN into $311 million in subsequent funding to support their research. [16] The 123 grantees evaluated authored 1,983 articles in peer-reviewed biomedical journals. [16]

In addition to receiving financial support for their research projects, grantees participate in the organization's Community for Progress, which consists of researchers working together to accelerate scientific and medical advances. [14]

PanCAN's Scientific and Medical Advisory Board is composed of leading cancer scientists, clinicians and healthcare professionals from institutions across the United States who specialize in pancreatic cancer. [17] They provide scientific and clinical expertise to guide PanCAN in planning and implementing research initiatives, in-depth information and educational services for patients, their families and caregivers, as well as healthcare professionals. [17]

Advocacy

The Government Affairs & Advocacy office of the Pancreatic Cancer Action Network was established in Washington, D.C., in 2006. [9] As a result of the office’s efforts, Dr. Randy Pausch testified in support of the cause and PanCAN in the House Appropriations Subcommittee on L-HHS in 2008 about the need for increased funding for pancreatic cancer research. [18]

In 2008, thousands of supporters delivered nearly 19,000 communications to their federal legislators requesting greater research funding. [19] The National Cancer Institutes (NCI) raised pancreatic cancer research funding from $73 million to $87 million.

Over 11,000 political supporters relayed more than 26,000 messages to their congressional lawmakers in 2009, getting the NCI another $70 million. [19]

Around $135 million went to the NCI in 2010 as well because of the advocates’ actions, which was a major win since many federal programs were being downsized. [19]

In 2011, the Department of Defense's Peer Reviewed Cancer Research Program (PRCRP) added pancreatic cancer. Approaching nearly $4 million, 12 research grants were dedicated to pancreatic cancer. [19]

Congresswoman Alma Adams and her staff wearing purple in support of PanCAN in 2019 Alma Adams and staff supporting PANCAN 2019.jpg
Congresswoman Alma Adams and her staff wearing purple in support of PanCAN in 2019

The passage of the Recalcitrant Cancer Research Act in 2012 called for the NCI to create a strategic plan for pancreatic and lung cancers. [19]

From the founding of PanCAN in 1999 to 2013, NCI research funding for pancreatic cancer grew 500 percent, totaling over $100 million. [19]

The 21st Century Cures Act passed in 2016, authorizing an additional $4.8 billion in new funding for the National Institutes of Health (NIH), with $1.8 billion for the National Cancer Moonshot Initiative. [20]

In 2017, Congress approved the second $2 billion increase in a row for the NIH in FY17. [21] Plus, $60 million in funding was approved for the Department of Defense's PRCRP, a $10 million increase over the previous fiscal year. [21]

The year also included the 10th anniversary of PanCAN's annual advocacy event called, "National Pancreatic Cancer Advocacy Day" in Washington, D.C., with hundreds of attendees, including survivors and their families, meeting with legislators to ask them to increase federal funding for cancer research. [22]

Programs and Services

Patient Services

Formerly known as Patient and Liaison Services, and Patient Central, the call center offers free disease information and services that are personalized for caregivers, patients and healthcare professionals. [23]

Know Your Tumor

The precision medicine service, initiated in 2014, uses molecular profiling to give doctors and their patients, who qualify for the program, details about the biology of their tumor to help select better treatment options. [10]

Clinical Trial Finder

Launched in 2015, the free online resource offers patients, caregivers and healthcare professionals access to an extensive directory of U.S. pancreatic cancer clinical trials. [11] The tool generates a number of trials that fit a patient's requirements.

Patient Registry

Developed in 2016, the online directory collects patient experiences to show similarities in the pancreatic cancer journey to advance researcher knowledge about the disease and improve patient therapies. [24]

Precision Promise

The initiative began in 2016 as the first precision medicine clinical trial to get new therapies to pancreatic cancer patients faster. [12]

Survivor & Caregiver Network

The program consists of survivors and caregivers who volunteer across the U.S. to speak with patients, caregivers, family members or friends about the disease. [23]

Community events and volunteer network

PanCAN has raised over $87 million for the pancreatic cancer cause through community events from 2008 to 2016. [9]

PurpleStride

The Pancreatic Cancer Action Network's main fundraising event is a 5K walk/run called PurpleStride. As of 2017, the events have involved around 80,000 people in nearly 60 communities across the United States. [7] PurpleStride contributors raised $11.8 million in 2017. [25]

Volunteer Affiliates

PanCAN's network of volunteer affiliates organize community events, build relationships with local media and meet with elected officials and businesses to spread awareness and raise funds. 58 affiliates across the U.S. were in operation in 2017. [25]

Wage Hope My Way

PanCAN's do-it-yourself (DIY) fundraising program is for individuals to host personal events in support of the cause. Nearly $1.3 million was raised in 2017. [25]

Partners

World Pancreatic Cancer Coalition

In 2013, international patient advocacy organizations focused on pancreatic cancer gathered to consider collaborating to raise awareness worldwide about the disease and supporting the work of one another. [26]

In 2016, the World Pancreatic Cancer Coalition started with over 40 organizations from more than 20 countries. [26] They currently host over 70 member organizations from more than 30 countries. [26] PanCAN president and CEO Julie Fleshman serves as chair of the World Pancreatic Cancer Coalition Steering Committee. [26]

Deadliest Cancers Coalition

The Deadliest Cancers Coalition was founded by the Pancreatic Cancer Action Network in 2008. [27] It is a consortium of patient advocacy organizations and professional societies from across the United States dedicated to resolving issues of policies involving the nation’s most lethal, or recalcitrant, cancers, which have five-year relative survival rates below 50 percent. [27]

Ratings and financials

2018 marked the 14th consecutive year the Pancreatic Cancer Action Network earned the highest four-star rating from Charity Navigator, the leading charity evaluator in the United States. [4]

Based on the Pancreatic Cancer Action Network’s IRS 990 form for FY2018, the organization posted revenue of $51,943,557. [2]

Staff

In 2018, the president and chief executive officer of the organization was Julie Fleshman. [28]

Related Research Articles

<span class="mw-page-title-main">Cancer Research UK</span> Cancer research and awareness charity

Cancer Research UK (CRUK) is the world's largest independent cancer research organisation. It is registered as a charity in the United Kingdom and Isle of Man, and was formed on 4 February 2002 by the merger of The Cancer Research Campaign and the Imperial Cancer Research Fund. Cancer Research UK conducts research using both its own staff and grant-funded researchers. It also provides information about cancer and runs campaigns aimed at raising awareness and influencing public policy.

The National Cancer Institute (NCI) coordinates the United States National Cancer Program and is part of the National Institutes of Health (NIH), which is one of eleven agencies that are part of the U.S. Department of Health and Human Services. The NCI conducts and supports research, training, health information dissemination, and other activities related to the causes, prevention, diagnosis, and treatment of cancer; the supportive care of cancer patients and their families; and cancer survivorship.

<span class="mw-page-title-main">Leukemia & Lymphoma Society</span> North American blood cancer charitable organization

The Leukemia & Lymphoma Society (LLS), a 501(c)(3) charitable organization founded in 1949, is a voluntary health organization dedicated to fighting blood cancer world-wide. LLS funds blood cancer research on cures for leukemia, lymphoma, Hodgkin's disease, and myeloma. It provides free information and support services, and it advocates for blood cancer patients and their families seeking access to quality and affordable care.

The Canadian Cancer Society is Canada's largest national cancer charity and the largest national charitable funder of cancer research in Canada.

<span class="mw-page-title-main">Susan G. Komen for the Cure</span> American non-profit organization

Susan G. Komen is a breast cancer organization in the United States.

<span class="mw-page-title-main">European Organisation for Research and Treatment of Cancer</span> International nonprofit organization

The European Organisation for Research and Treatment of Cancer (EORTC) is a unique pan-European non-profit clinical cancer research organisation established in 1962 operating as an international association under Belgium law. It develops, conducts, coordinates and stimulates high-quality translational and clinical trial research to improve the survival and quality of life of cancer patients. This is achieved through the development of new drugs and other innovative approaches, and the testing of more effective therapeutic strategies, using currently approved drugs, surgery and/or radiotherapy in clinical trials conducted under the auspices of a vast network of clinical cancer researchers supported by 220 staff members based in Brussels. The EORTC has the expertise to conduct large and complex trials especially specific populations such as the older patient and rare tumours.

<span class="mw-page-title-main">St. Baldrick's Foundation</span> American nonprofit organization

The St. Baldrick’s Foundation is a volunteer and donor-powered charity committed to supporting the most promising research to find cures for childhood cancers and give survivors long and healthy lives. The name of the foundation is not associated with a recognized Saint of the Catholic Church, but is founded on wordplay and appropriation of the title of sainthood. Volunteers sponsored by family, friends, and employers shave their heads or "chop" their ponytails in solidarity with children who typically lose their hair during cancer treatment in order to raise funds. Charity Navigator gave the foundation a 79 out of a possible 100 score rating and a three-star rating out of a possible 4 Star rating. According to Better Business Bureau, the non-profit meets the 20 Standards for Charity Accountability, St. Baldrick's Foundation now has the GuideStar Gold Seal of approval.

<span class="mw-page-title-main">City of Hope National Medical Center</span> U.S. clinical research center and hospital

City of Hope is a private, non-profit clinical research center, hospital and graduate school located in Duarte, California, United States. The center's main campus resides on 110 acres (45 ha) of land adjacent to the boundaries of Duarte and Irwindale, with a network of clinical practice locations throughout Southern California, satellite offices in Monrovia and Irwindale, and regional fundraising offices throughout the United States.

The Lupus Foundation of America (LFA), founded in 1977, is a national voluntary health organization based in Washington, D.C., with a network of chapters, offices and support groups located in communities throughout the United States. The Foundation is devoted to solving the mystery of lupus. Its mission is to improve the quality of life for all people affected by lupus through programs of research, education, support and advocacy.

<span class="mw-page-title-main">American Cancer Society Cancer Action Network</span> American nonprofit advocacy organization

The American Cancer Society Cancer Action Network is a nonprofit, nonpartisan advocacy affiliate of the American Cancer Society. It was founded in September 2001 to directly lobby the goals of the American Cancer Society, which is subject to restrictions on advocacy activities because of its tax classification. ACS CAN works to make cancer a national priority. Specifically, it advocates for better access to care, cancer prevention and early detection programs, cancer research funding, regulation of tobacco by the U.S. Food and Drug Administration, better quality of life for cancer patients, and attempts to raise awareness of and reduce cancer disparities. Members include cancer survivors, caregivers, patients, volunteers, and students, including Colleges Against Cancer.

The "war on cancer" is the effort to find a cure for cancer by increased research to improve the understanding of cancer biology and the development of more effective cancer treatments, such as targeted drug therapies. The aim of such efforts is to eradicate cancer as a major cause of death. The signing of the National Cancer Act of 1971 by United States president Richard Nixon is generally viewed as the beginning of this effort, though it was not described as a "war" in the legislation itself.

<span class="mw-page-title-main">Prostate Cancer Foundation</span> American non-profit organization

The Prostate Cancer Foundation (PCF), headquartered in Santa Monica, California, funds research into the prevention and cure of prostate cancer.

The Office of Cancer Complementary and Alternative Medicine (OCCAM) is an office of the National Cancer Institute (NCI) in the Division of Cancer Treatment and Diagnosis. OCCAM was founded in 1998 and is responsible for NCI's research agenda in pseudoscientific complementary and alternative medicine (CAM), as it relates to cancer prevention, diagnosis, treatment, and symptom management. The OCCAM differs from the National Center for Complementary and Integrative Health in that it is exclusively focused on cancer, while the NCCIH funds a much broader program of NIH research into CAM for all diseases and disorders. It last produced an annual report in 2011 and spent $105 million on CAM research in 2011.

The Cancer Trials Support Unit(CTSU) is a service of the National Cancer Institute (NCI) in the United States.

The Lustgarten Foundation is a 501(c)(3) non-profit organization foundation dedicated to advancing the research related to the diagnosis, treatment, cure and prevention of pancreatic cancer while raising public awareness and providing support to patients and their families. The Foundation is the largest private funder of pancreatic cancer research in the world. Based in Woodbury, Nassau County, New York, the Foundation's mission is to cure pancreatic cancer by funding scientific and clinical research related to the diagnosis, treatment, and prevention of pancreatic cancer; providing research information and clinical support services to patients, caregivers and individuals at high risk; and increasing public awareness and hope for those dealing with this disease. Increasing funding and support of research into the biological mechanisms and clinical strategies related to the prevention, diagnosis, and treatment of pancreatic cancer; Facilitating and enhancing the dialogue among members of the medical and scientific communities about basic and clinical research efforts that relate to pancreatic cancer; Heightening public awareness of pancreatic cancer diagnosis, treatment, and prevention and providing informational support for pancreatic cancer patients, their families, and friends.

Ovarian Cancer Research Alliance (OCRA) is a not-for-profit organization focused on ovarian cancer research, advocacy and patient support. The organization was formed in January 2016 when the former not-for-profit organization Ovarian Cancer Research Fund, which focused primarily on ovarian cancer research, combined with Ovarian Cancer National Alliance, which focused primarily on ovarian cancer advocacy and support programs, to form one organization.

<span class="mw-page-title-main">Inspire (company)</span> American social network

Inspire is an Arlington, Virginia-based healthcare social network. It builds and manages online health communities for patients and caregivers, and connects patients to life science companies for the purpose of research.

The Parkinson's Foundation is a national organization that funds research and provides educational resources to Parkinson’s disease patients and caregivers. The Parkinson's Foundation was established in 2016 through the merger of the National Parkinson Foundation and the Parkinson's Disease Foundation. The Parkinson's Foundation has headquarters in Miami and New York City, in addition to 17 chapters throughout the United States.

<span class="mw-page-title-main">Children's Cancer Foundation (Australia)</span>

The Children's Cancer Foundation is a registered Australian charity that supports children with cancer and their families.

<span class="mw-page-title-main">Andrew Biankin</span>

Andrew Victor Biankin is a Scotland-based Australian clinician-scientist, best known for his work on enabling precision oncology in learning healthcare systems by integrating discovery, preclinical and clinical development to accelerate novel therapeutic strategies, and developing standardised pan-cancer assays for use by healthcare systems and researchers worldwide.

References

  1. ↑ "Pancreatic Cancer Action Network, Inc.". Business Search. California Secretary of State. Retrieved March 31, 2017.
  2. 1 2 3 4 5 6 7 8 9 "Form 990: Return of Organization Exempt from Income Tax". Pancreatic Cancer Action Network. June 30, 2018.
  3. ↑ "Pancreatic Cancer Action Network Inc.". Exempt Organizations Select Check. Internal Revenue Service. Retrieved March 31, 2017.
  4. 1 2 3 4 "Charity Summary: Pancreatic Cancer Action Network". Charity Navigator. Retrieved July 1, 2018.
  5. ↑ Welch, Ashley. "Yankees' David Robertson on the Devastating Toll of Pancreatic Cancer". CBS News. Retrieved November 16, 2017.
  6. ↑ Rahib, L; Matrisian, L; Aizenberg, R; Rosenzweig, A (June 1, 2014). "Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States". Cancer Research. 74 (11): 2913–21. doi:10.1158/0008-5472.CAN-14-0155. PMID   24840647.
  7. 1 2 Ford, Jack. "A Purple Prospect". PBS MetroFocus. Retrieved April 7, 2017.
  8. ↑ Price, Diana. "Advocacy Spotlight: Pancreatic Cancer Action Network". Cancer Fighters Thrive. Retrieved June 1, 2013.
  9. 1 2 3 4 5 6 7 8 9 10 "About Us: Our History of Achievements". Pancreatic Cancer Action Network. Retrieved November 14, 2018.
  10. 1 2 Helwick, Caroline. "Know Your Tumor Program Aids Patients with Pancreatic Cancer". The ASCO Post. Retrieved March 25, 2016.
  11. 1 2 Engebretson, Anitra. "Connect Your Patients with Pancreatic Cancer Clinical Trial Options". Oncology Nursing News. Retrieved May 17, 2015.
  12. 1 2 Begley, Sharon. "Novel Pancreatic Cancer Effort Aims to Give Patients More Treatment Options". Scientific American. Retrieved October 5, 2016.
  13. ↑ "Public Access Policies: Foundations, Charities and Organizations". Bernard Becker Medical Library. Retrieved August 23, 2016.
  14. 1 2 "Pancreatic Cancer Action Network-AACR Research Grants Presentation Session". American Association for Cancer Research. Retrieved April 20, 2016.
  15. ↑ "Dr. Ingunn Stromnes awarded the 2019 Julia Stagliano Pancreatic Cancer Action Network Catalyst Grant". Center of Immunology-University of Minnesota. Retrieved August 23, 2019.
  16. 1 2 3 "Grants Program Evaluation Results". Pancreatic Cancer Action Network. Retrieved January 3, 2019.
  17. 1 2 "Simeone Named Upcoming Chair of Pancreatic Cancer Action Network Scientific Board". Michigan Medicine. 10 August 2015. Retrieved August 10, 2015.
  18. ↑ Duff, Michelle (2008). "Randy Pausch: The Man Who Made Every Day Matter". Gastrointestinal Cancer Research. 2 (4): 215. PMC   2632834 . PMID   19259289.
  19. 1 2 3 4 5 6 "Advocate for Federal Research Funding". Pancreatic Cancer Action Network. Retrieved November 14, 2018.
  20. ↑ Kaplan, Shelia. "Who Wins and Loses with the 21st Century Cures Act?". PBS NewsHour . Retrieved December 6, 2016.
  21. 1 2 "How Science Fares in the U.S. Budget Deal". Science Magazine. May 2017. Retrieved May 1, 2017.
  22. ↑ Hanabusa, Colleen. "Waging Hope in Memory of Our Colleagues". The Hill. Retrieved June 1, 2017.
  23. 1 2 Fleshman, J. (2009). "Pancreatic Cancer Action Network: Advance Research, Support Patients, and Create Hope". Journal of Oncology Practice. 5 (2): 98. doi:10.1200/JOP.0924502. PMC   2790643 . PMID   29443615.
  24. ↑ "FasterCures Innovator Spotlight: Pancreatic Cancer Action Network". Milken Institute. Retrieved June 22, 2015.
  25. 1 2 3 "Annual Reports: Impact Report 2017". Pancreatic Cancer Action Network. Retrieved November 14, 2018.
  26. 1 2 3 4 "About Us: World Pancreatic Cancer Coalition". World Pancreatic Cancer Coalition. Retrieved December 3, 2018.
  27. 1 2 "Home: Deadliest Cancers Coalition". Deadliest Cancers Coalition. Retrieved December 3, 2018.
  28. ↑ "What makes pancreatic cancer so deadly?". CBS News. Retrieved October 15, 2018.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.